PSYG Share Price Performance
Recent PSYG News & Updates
No updates
Psyence Group Inc. Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -4.21
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
Psyence Group Inc. Competitors
About PSYG
- Founded
- 2019
- Employees
- n/a
- CEO
- WebsiteView website
Psyence Group Inc., a life science biotechnology company, engages in the cultivation and production of commercial psilocybin mushroom. It operates in two segments: Clinical Trial Activities and Non-Clinical Trial Activities. The company natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. It also focuses on the development, distribution, and sale of over-the-counter non psilocybin containing functional mushroom nutraceutical products under the GOODMIND brand. The company was founded in 2019 and is based in Toronto, Canada.
Canadian Market Performance
- 7 Days: 0.9%
- 3 Months: 11.0%
- 1 Year: 18.4%
- Year to Date: 10.4%
The market has been flat in the last week, however the Industrials sector is down 3.1%. More promisingly, the market is up 18% over the past year. As for the next few years, earnings are expected to grow by 12% per annum. Market details ›
The tide is turning for UK & European markets. Index ETFs won’t cut it since sector spreads are massive. Picking the right companies matters now more than ever.
Continue readingLast Week
